All View

Product Information
Registration Number BR-1307
Generic Name Varicella Vaccine (Live, Attenuated)
Brand Name Varilrix
Dosage Strength Formulation: After reconstitution, one dose (0.5 mL) contains not less than 103.3 plaque-forming units (PFU) live attenuated varicella-zoster virus (Oka Strain).
Dosage Form Lyophilized Powder For Injection (S.C.)
Classification Prescription Drug (RX)
Packaging Type I colorless glass vial with bromobutyl rubber stopper and flip-off cap + 0.5 mL Type I pre-filled glass syringe (Water for Injection as diluent) with 2 separate needles (Box of 1's)
Pharmacologic Category Vaccine
Manufacturer GlaxoSmithKline Biologicals SA
Country of Origin Belgium
Trader N/A
Importer GlaxoSmithKline Philippines, Inc.
Distributor GlaxoSmithKline Philippines, Inc.
Application Type Initial (Variation)
Issuance Date 25 July 2023
Expiry Date 25 July 2028